BSE filing, NSE: SWORDEDGE. Summary written from the filing by ALFA Finder's alert engine.
Sword-Edge Commercials Ltd: key numbers
- Share price
- ₹0.26
- Market cap
- ₹5.65 Cr
- Revenue (annual)
- ₹2.06 Cr
- Net profit (annual)
- ₹-0.54 Cr
- P/E (TTM)
- -5.5×Sector 45.2×
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Sword-Edge Commercials Ltd
All →Sword-Edge Commercials Board Meeting Date
Sword-Edge Commercials will hold a board meeting on 3 November 2026 for unaudited standalone results. The trading window reopens 48 hours after results are declared.
Sword-Edge Commercials Management Change
Sword-Edge Commercials Ltd announced Independent Director Mr. Manish Kumar's resignation effective September 16, 2026, citing personal reasons. He also steps down from all board committees.
Sword-Edge Commercials Management Change
Sword-Edge Commercials Ltd appointed Mr. Ashish Anand as a Non-Executive Independent Director, effective September 7, 2026.
Sword-Edge Commercials Board Meeting Outcome
The Board appointed Mr. Ashish Anand as an Additional Non-Executive Independent Director and designated Mr. Tushar Parekh as Senior Management Personnel during its meeting.
Other other announcement announcements
All →STL Networks Other Announcement
The Monitoring Agency reported Rs. 2 Crore utilization of Preferential Issue proceeds, with no deviations from objects. The report covers the quarter ending September 30, 2026.
HEG Advanced Materials Other Announcement
HEG Advanced Materials Limited has intimated the exchange regarding the change of its Corporate Identification Number (CIN) following an approved scheme of arrangement.
Sanofi India Other Announcement
Sanofi India issued a communication regarding Tax Deduction at Source (TDS) for the interim dividend declared for FY 2026. Shareholders must update details by November 5, 2026.
Visaka Industries Other Announcement
Visaka Industries informed the exchange about sending reminder letters to shareholders regarding the compulsory transfer of unclaimed dividends and equity shares to the IEPF account.
Arvaya Healthcare Other Announcement
Arvaya Healthcare filed its quarterly shareholding pattern under Regulation 31(1)(c). The filing reports routine ownership breakdowns with no transaction.
AYM Syntex Other Announcement
AYM Syntex's board appointed BSR & Co. LLP as statutory auditor for five years, subject to shareholder approval. Routine auditor appointment; no monetary value involved.
- Execution
- Five consecutive years, from the conclusion of the 44th AGM to the conclusion of the 49th AGM